CRISPR-Cas9 is advancing Parkinsonโs Disease research through precise gene editing, improved models, and emerging gene-therapy options.
Join global leaders discussing these breakthroughs at OTDC 2026.
๐ May 25โ26, 2026 | ๐ Rome, Italy
๐
#
CRISPR# #
Cas9#